Reduce Inflammation in Allergen-Induced Asthma by Herbal Medicine Treatment – AccentedTouch


AccentedTouch

Reduce Inflammation in Allergen-Induced Asthma by Herbal Medicine Treatment
AccentedTouch
Researchers have found that a traditional Korean medicine that has protracted been used for the treatment of allergic diseases in Asia can lessen inflammation in allergen-induced asthma. “Researchers from Boston University School of Medicine (BUSM),

View full post on asthma – Google News

Botox and Asthma: An Unlikely Treatment – ThirdAge


ThirdAge

Botox and Asthma: An Unlikely Treatment
ThirdAge
Botox and asthma seem like an unlikely pair. One paralyzes muscles and removes wrinkles, while the other restricts air flow. It doesn't seem like paralysis would be useful in letting more air through, but that's exactly the hypothesis put forth by
Botox Being Sought To Help Asthma SufferersThe Inquisitr
Botox: Asthma Treatment – Will It Work?Gather.com

all 5 news articles »

View full post on asthma – Google News

Herbal medicine treatment reduces inflammation in allergen-induced asthma … – Science Daily (press release)

Herbal medicine treatment reduces inflammation in allergen-induced asthma
Science Daily (press release)
These findings appear online in the Annals of Allergy, Asthma & Immunology. Asthma is a unique form of chronic respiratory disease characterized by reversible airway obstruction and pulmonary inflammation. It represents one of the most common chronic

View full post on asthma – Google News

Botox to be trialled as treatment for severe asthma – ABC Online


Leader News

Botox to be trialled as treatment for severe asthma
ABC Online
ELEANOR HALL: Soon Botox might not only be used to eliminate wrinkles, but to smooth the way for sufferers of asthma. Melbourne clinicians are about to start a trial using the toxin to treat severe asthma conditions. As Mary Gearin reports it is the
Monash Medical Centre to trial botox asthma treatmentLeader News
Botox to smooth breathing for asthmatics say Monash Medical Centre researchersPerth Now
Botox to smooth breathing for asthmaticsNEWS.com.au

all 23 news articles »

View full post on asthma – Google News

Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment.

Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment.

Semin Respir Crit Care Med. 2011 Jun;32(3):298-309

Authors: Dunogué B, Pagnoux C, Guillevin L

Churg-Strauss syndrome (CSS), first described in 1951, is a rare vasculitis of small- and medium-sized vessels. It is characterized by a constant association with asthma and eosinophilia, and by the presence of anti-myeloperoxidase (MPO) anti-neutrophil cytoplasmic antibodies (ANCA) in ~40% of the patients. Vasculitis typically develops in a previously asthmatic and eosinophilic middle-aged patient and most frequently involves the peripheral nerves and skin. Other organs, however, may be affected and must be screened for vasculitis, especially those associated with a poorer prognosis, such as the heart, kidney, and gastrointestinal tract, as assessed by the recently revised Five-Factor Score (FFS). Overall survival of CSS patients is excellent, but relapses are not uncommon and require maintenance or steroid-sparing therapies, depending on the original FFS-based prognosis at diagnosis. All patients require corticosteroids, often for prolonged periods, combined with immunosuppressants [e.g., induction (cyclophosphamide) and maintenance therapy (azathioprine)], for those with poorer prognoses. Recent insights, especially concerning clinical differences associated with ANCA status, showed that CSS patients might constitute a heterogeneous group, both clinically and pathogenically. Future therapies might reflect these differences more strongly.

PMID: 21674415 [PubMed – in process]

View full post on pubmed: asthma